Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors

Feb. 4, 2022

DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity

Feb. 1, 2022

OR6A2 is a therapeutic target for atherosclerosis, researchers unveil

Feb. 1, 2022

Cereno advances CS-014 for cardiovascular diseases

Jan. 28, 2022

Therapeutic CAR T cells generated in the body reduce fibrosis in heart disease model in vivo

Jan. 26, 2022

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

Jan. 21, 2022

Researchers suggest ZEB2 targeting as an approach for atherosclerosis

Jan. 18, 2022

Targeting GNAO1 presents a new therapeutic strategy for heart failure

Jan. 13, 2022

VCAM-1-targeting polyelectrolyte complex enhances therapeutic efficacy of miR-92a inhibitors in vivo

Jan. 12, 2022

DiNAQOR and CMRI enter research collaboration on cardiac specific AAV capsids

Jan. 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...